Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations

Filed Under: Pharma Tagged With: , , , ,

Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) and Sumitomo Chemical Co. Ltd. (TYO:4005) plan to expand their CDMO facilities for regenerative…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsubishi Chemical Holdings to Turn Mitsubishi Tanabe Pharma Into Wholly Owned Subsidiary
Mitsubishi Chemical Holdings to Turn Mitsubishi Tanabe…
Sumitomo Chemical President Keiichi Iwata Lays out Plan to Get Core Operating Income to 280B Yen
Sumitomo Chemical President Keiichi Iwata Lays out Plan to…
Teijin Expands Health Care Operations for Bone and Joint Diseases
Teijin Expands Health Care Operations for Bone and Joint…
Sumitomo Chemical Plans Silicon Valley Startup Support Hub
Sumitomo Chemical Plans Silicon Valley Startup Support Hub
Fujifilm, JSR Stand out Among Major Chemical–Material Manufacturers in Health Care-Related Operations for First Half
Fujifilm, JSR Stand out Among Major Chemical–Material…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…